Find Academic Supervisors

Maria Fällman is a Professor at the Department of Molecular Biology at Umeå University, where she also serves as Deputy Head of Department. She is affiliated with Molecular Infection Medicine Sweden (MIMS), a leading research center for molecular infection medicine in Sweden. Dr. Fällman's research focuses on understanding the molecular mechanisms behind bacterial adaptation to different environments, with particular emphasis on Yersinia pseudotuberculosis and Salmonella enterica Typhimurium. Her group investigates gene regulation critical for establishing and maintaining infections, bacterial stress responses, and the molecular mechanisms of the Type Three Secretion System (T3SS). The lab has developed advanced methods for RNA extraction from complex tissue samples and performs in vivo gene expression analyses. Her publication record shows consistent contributions to understanding bacterial pathogenesis, with recent articles in high-impact journals including Nature Communications, Science, and PLOS Pathogens. Her work spans from fundamental molecular mechanisms of bacterial virulence to computational approaches for analyzing pathogen stress responses. A significant contribution is the PATHOgenex database (http://www.pathogenex.org), containing gene expression data of over 30 human pathogens exposed to different stress conditions. Dr. Fällman leads the Maria Fällman Lab, which has made important discoveries including the finding that sub-lethal doses of Yersinia result in persistent infection in mice with reprogramming of bacterial gene expression. Current projects focus on stress response modeling and deciphering heterogeneous populations of infecting bacteria using single-cell RNA-seq.

• Molecular microbiology
• Bacterial pathogenesis
• Infection biology
• +7 more

Anna Johansson is an Assistant Professor at the Karolinska Institutet , leading research in cancer epidemiology and biostatistics at the Department of Medical Epidemiology and Biostatistics . She serves as a Docent and group leader, with affiliations at Karolinska University Hospital, Capio St Göran Hospital, and Uppsala University Hospital. Research Interests: Her work spans Cancer epidemiology with focus on breast cancer Reproductive factors and cancer risk Socioeconomic inequalities in healthcare Applied biostatistics and register-based methods Nordic cross-country collaborations Recent Article Trends show emphases on Nordic cancer survival comparisons Pregnancy-associated cancer outcomes Stage-specific mortality analysis Impact of healthcare disruptions Statistical methods for registry data Fertility preservation in oncology Scientific Awards Senior Investigator Award, Swedish Cancer Society Teaching & Mentorship includes survival analysis, epidemiological designs, and data management workshops within the Karolinska Doctoral Programme. She supervises PhD students in cancer and reproductive epidemiology. Collaborative Networks extend to the Nordic Cancer Union, Cancer Registry of Norway, and clinical research teams across Sweden and the Nordic region.

• Cancer Epidemiology
• Breast Cancer
• Reproductive Epidemiology
• +3 more

William A. Nyberg is an Assistant Professor at the Department of Medicine, Huddinge, Karolinska Institutet. His research focuses on the in vivo genetic modification of T cells for cancer treatment, utilizing chimeric antigen receptors (CARs), CRISPR/Cas9, and synthetic vectors like adeno-associated viruses (AAVs) and lipid nanoparticles (LNPs). The lab aims to eliminate time-consuming ex vivo manufacturing processes and enhance CAR-T cell efficacy in immunosuppressive tumor microenvironments. Assistant Professor, Department of Medicine, Huddinge (2024–2030) SciLifeLab Fellow (2024–2030) European Research Council grant recipient (2025–2029) Recruiting postdoctoral fellows, doctoral, and master's students His work intersects Genetic Engineering, Immunology, and Oncology, with key subfields including CAR-T cell therapy, CRISPR/Cas9, tumor microenvironment, and synthetic biology. Collaborative projects involve Yenan Bryceson's group and translational humanized/syngeneic mouse models. Scientific Awards: SciLifeLab Fellow (Karolinska Institute, 2024–2030) Advising: Julian Fischbach (Doctoral student)

• Genetic Engineering
• Immunology
• Oncology
• +5 more

Dr. Gabriel Sandblom is a Senior Lecturer and Senior Physician at the Karolinska Institutet's Department of Clinical Science and Education, Södersjukhuset. His research group focuses on improving outcomes in gallstone surgery, abdominal wall surgery, and acute pancreatitis through population-based studies and clinical trials. He leads projects on gallstone disease management , hernia repair techniques , and quality of life assessments post-surgery. The group's recent publications (2025-2016) span topics such as laparoscopic cholecystectomy optimization , hernia repair complications , and acute surgical care . Articles emphasize comparative surgical techniques (ultrasonic vs electrocautery), patient safety , and long-term functional outcomes after procedures like diastasis recti repair . Studies often use Swedish national registries to analyze trends in acute cholecystitis and colorectal surgery . Key collaborators include Drs. Enochsson, Österberg, and Ali . His work addresses weekend surgery outcomes , retained gallstones , and ERAS protocols in gastrointestinal surgery. The group also explores interprofessional teamwork and surgical training innovations like virtual simulators.

• Surgery
• Acute Care Surgery
• Gallstone Disease
• +3 more

Professor Tomas Jansson serves as faculty at Lund University's Faculty of Engineering within the Department of Biomedical Engineering, holding concurrent roles as Supervisor, Head of Office for Biomedical Engineering, Project Manager for Medical Ultrasound, Director of Medicon Bridge, and member of both LTH's Engineering Health and LU's Light and Materials profile areas. His research centers on ultrasound-based diagnostic and therapeutic innovations, particularly utilizing iron oxide nanoparticles as ultrasound contrast agents for early cancer detection and surgical guidance. Current work also explores virtual reality systems for mobility assessment in visually impaired populations through the AUDOMNI sensory supplementation project. Key research domains include nanoparticle engineering, ultrasonics, transducer development, and lymph node imaging. Recent publications demonstrate dual research thrusts: (1) advanced ultrasound techniques for gastrointestinal disease diagnosis using ultra-high frequency imaging and nanoparticle-enhanced magnetomotive ultrasound, and (2) virtual reality-based mobility assessment tools with audio feedback systems for blind navigation. These efforts directly support UN Sustainable Development Goals in health and well-being. Professor Jansson actively supervises doctoral candidates including J. Berggreen (AI ultrasound applications) and J. Isaksson-Daun (AUDOMNI navigation system), while securing major funding from the Swedish Research Council and Mrs. Berta Kamprad's Cancer Foundation for prostate cancer nanotechnology projects extending through 2029. He leads the Ultrasound group infrastructure within Biomedical Engineering and participates in academic outreach through initiatives like the Medicinteknik i Skåne conference organization.

• Ultrasound Imaging
• Nanoparticle Engineering
• Medical Diagnostics
• +3 more

Gabriella Lillsunde-Larsson is a Senior Lecturer and Associate Professor at the Örebro University School of Health Sciences , with a 30% appointment at the Department of Laboratory Medicine, Örebro University Hospital. Her work bridges biomedical laboratory science and clinical oncology , focusing on HPV-induced cancers and translational research. PhD in Biomedicine (2015) - Thesis: Characterization of HPV-induced vaginal and vulvar carcinoma Current research projects: HPV gene variation and protein expression as prognostic markers Molecular triage for cervical screening Prognostic biomarkers in prostate cancer Research Focus: Gabriella investigates biological and prognostic factors in HPV-induced genital cancers, prostate cancer, and endocannabinoid signaling. Her work includes cost-effectiveness analysis of self-sampling methods and international collaborations on cervical screening policies. Publications: Recent work explores molecular triage in cervical screening, HPV genotyping in HIV-endemic regions, and protein expression markers in vaginal carcinoma. Her studies (2022-2025) emphasize translational applications of HPV research and laboratory science innovations. Academic Leadership: Program Manager for the Master's Program in Methods in Medical Diagnostics Vice Chair of the Institute of Biomedical Laboratory Science (IBL) President of the International Federation of Biomedical Laboratory Science (IFBLS) since 2024 Örebro University representative in the Regional Cancer Center (RCC) Central Sweden International Engagement: Active in WHO collaborations through IFBLS, scientific committee member for global HPV congresses, and contributor to professional education standards across Nordic countries.

• Biomedicine
• Virology
• Oncology
• +5 more

Marjan Firouznia is a Principal Research Engineer at Linköping University , affiliated with the Division of Diagnostics and Specialist Medicine (DISP) under the Faculty of Medicine and Health Sciences . With a PhD in Electrical Engineering from Amirkabir University of Technology and postdoctoral experience at institutions like Case Western Reserve University, she specializes in advancing machine learning models for precise segmentation of cardiac structures including the left atrium , epicardial fat , and fibrosis using CT and MRI scans. Her work aims to improve diagnostic accuracy and treatment planning in cardiovascular care. Marjan's research focuses on medical imaging , deep learning , and computational anatomy , with recent publications on FractalRG , FK-means , and Poincare-guided UNet for cardiac structure segmentation. Her academic contributions span 15 recent publications , emphasizing fractal geometry , chaos theory , and optimization algorithms in biomedical applications. She actively develops open-source datasets and tools, such as the FK-means codebase , to support reproducibility in medical AI research.

• Medical Imaging
• Machine Learning
• Deep Learning
• +3 more

Olli-Pekka Kallioniemi is a Professor of Molecular Precision Medicine and Director of Science for Life Laboratory (SciLifeLab) at Karolinska Institutet. He leads the Precision Cancer Medicine research group within the Department of Oncology-Pathology, focusing on translational research to improve cancer treatment through ex vivo drug testing and multi-omics profiling. His work bridges laboratory discoveries with clinical applications, emphasizing actionable insights for personalized therapy. Research Interests: Dr. Kallioniemi’s group develops functional precision medicine approaches to identify therapeutic vulnerabilities in cancers like AML, ovarian, prostate, and renal cancers. Techniques include patient-derived 2D/3D cell models, organoids, and comprehensive genomic/drug-response profiling. Their work progresses through three translational phases: model feasibility (Phase I), representativity optimization (Phase II), and clinical actionability (Phase III). Selected Achievements: - Directed 75 million SEK in grants from the Swedish Cancer Society (2022) - Pioneered functional drug testing platforms for solid tumors and hematologic malignancies - Coordinated multi-institutional collaborations between Karolinska Institutet and the Institute for Molecular Medicine Finland Labs/Teams: His group operates at SciLifeLab (Stockholm) and the Institute for Molecular Medicine Finland (Helsinki), with sub-teams like the Functional Systems Oncology group led by Dr. Tom Erkers. Core personnel include postdoctoral researchers, PhD students, and clinical assistants.

• Precision Cancer Medicine
• Functional Drug Testing
• Oncogenomics
• +3 more

Andreas Lundqvist is a Professor at the Department of Oncology-Pathology, Karolinska Institutet. His research focuses on understanding mechanisms of immune escape in solid tumors, particularly investigating NK and T cell regulation. He leads the Cell-based Immune Therapy for Cancer group, aiming to develop novel immunotherapies. Education & Roles: PhD in Immunology, Karolinska Institutet (2003) Professor since 2023; Associate Professor (2012–2023); Assistant Professor (2009–2012) Prior roles include Staff Scientist and Research Fellow at the National Institutes of Health (NIH) (2003–2008) Research Interests: Lundqvist's work targets immune evasion in cancer, with emphasis on NK and T cell dynamics. His group explores tumor microenvironment interactions, immune checkpoint modulation, and biomarker discovery. Recent studies focus on renal cell carcinoma, melanoma, and Hodgkin lymphoma. Grants & Funding: Swedish Childhood Cancer Fund (2024–2025) Swedish Research Council (2023–2026) Swedish Cancer Society (2022–2024) Advising & Labs: Lundqvist supervises a research group including PhD students and postdoctoral fellows. Notable alumni include Dhifaf Sarhan (Karolinska Institutet) and Erik Wennerberg (The Institute of Cancer Research).

• Cancer and Oncology
• Cell and Molecular Biology
• Immunology in the medical area

Christine Gustafsson is a Professor in Health Care Sciences at Sophiahemmet University's Department of Nursing. With over 25 years of academic experience, her research focuses on health and welfare technology (HWT) from user perspectives, particularly addressing aging populations and individuals with intellectual disabilities. She leads projects like iHACT, PROTECT, IN-AGE, and UPSCALE, emphasizing technology's role in enabling independent living and safe aging. Professional roles include Nordic Welfare Technology Research Network management, Forte Research Council board membership, and advisory roles to Sweden's Minister of the Elderly and Demensfonden. Education: Not explicitly detailed in provided texts Her research explores HWT implementation challenges in sparsely populated Nordic regions, emphasizing governance structures and user-centered design. Key projects like IN-AGE develop evaluation instruments for technology-supported independence. She co-created the robotic cat JustoCat and authored influential books on pedagogical approaches in care and welfare technology. Recent work analyzes cost-consequence studies of digital assistive technologies and explores FLASH radiotherapy dosimetry challenges. She consistently bridges clinical practice, policy, and technology through interdisciplinary collaboration.

• Health and Welfare Technology (HWT)
• Aging in Place
• Care for Older Adults
• +3 more

Maria Hedelin serves as a Senior Lecturer at Karolinska Institutet's Department of Medical Epidemiology and Biostatistics since 2023, specializing in nutrition-dietetics intersections with cancer epidemiology, particularly prostate cancer research through dietary interventions and biomarker analysis. She earned her Doctor of Philosophy (PhD) from Karolinska Institutet's Department of Medical Epidemiology and Biostatistics in 2006, establishing her academic foundation in epidemiological methods and nutritional sciences. Hedelin's research centers on nutritional oncology, investigating how phytoestrogens, dietary fiber, and fatty acids influence cancer development and progression. Her work bridges clinical practice and population health through randomized controlled trials like PRODICA and cohort studies examining dietary patterns in Swedish cancer populations. She develops innovative assessment tools including mobile applications for dietary monitoring, emphasizing methodological rigor in nutritional epidemiology. Analysis of her 15 most recent publications reveals consistent thematic focus on prostate cancer nutrition interventions, with evolving methodological sophistication from cohort studies (2008-2013) to contemporary randomized trials (2021-2025). Her research spans dietary assessment validation, genetic-diet interactions, radiotherapy side effect mitigation, and cross-cancer applications from prostate to breast and colorectal malignancies. No major scientific awards or prizes are documented in publicly available information regarding her career achievements. While specific student advising details remain unpublicized, her doctoral thesis supervision and extensive publication record suggest active mentorship roles. Departmental context indicates involvement in Karolinska's Medical Epidemiology and Biostatistics unit which recently secured 120 million SEK in Swedish research funding (2024), supporting collaborative projects in cancer epidemiology and nutritional interventions. As a core faculty member in one of Europe's leading medical research institutions, Hedelin contributes to Karolinska Institutet's mission through interdisciplinary collaborations spanning oncology, nutrition science, and biostatistics, with growing emphasis on personalized dietary approaches based on genetic profiling in cancer care.

• Nutrition
• Dietetics
• Cancer Epidemiology
• +3 more

Jussi Taipale is a Professor of Medical Systems Biology at Karolinska Institutet and holds professorships at University of Helsinki. His research focuses on transcription factor binding mechanisms , cancer genomics , and gene regulatory networks . The interdisciplinary Taipale Lab operates across three international locations: Wellcome Sanger Institute (UK), Karolinska Institutet (Sweden), and University of Helsinki (Finland), with over 20 members including senior scientists, postdoctoral fellows, and graduate students. Ph.D., University of Helsinki (1996) Postdoctoral training: University of Helsinki, Johns Hopkins University Research spans transcription factor cooperativity , epigenetic regulation , chromatin accessibility , and noncoding mutation analysis . Key methodologies include HT-SELEX , CUT&RUN , ATI assays , and CRISPR-based functional genomics . The lab has significantly advanced understanding of Myc-driven oncogenesis , TF-nucleosome interactions , and dinucleotide specificity mechanisms . Notable discoveries include chromatin context-dependent enhancers , water-mediated DNA recognition , and novel composite transcription factor motifs . The group maintains active collaborations across Europe and has trained numerous alumni now leading academic and industry positions worldwide.

• Gene regulation
• Transcription factors
• Systems biology
• +4 more

Susanna Larsson is an Associate Professor and Senior Researcher at Karolinska Institutet's Institute of Environmental Medicine, where she leads the Cardiovascular and Nutritional Epidemiology Unit. Her work spans multiple disciplines within public health research, with a particular focus on understanding the complex relationships between diet, lifestyle factors, and chronic disease development. Dr. Larsson's research interests primarily center around cardiovascular epidemiology, nutritional epidemiology, and cancer epidemiology, with a strong methodological emphasis on Mendelian randomization techniques. Her work frequently examines how dietary patterns, particularly meat consumption, plant-based diets, and specific nutrients, influence the risk of major chronic diseases including cardiovascular conditions, inflammatory bowel disease, and various cancers. She has made significant contributions to understanding the genetic and environmental determinants of disease through large-scale multinational studies and meta-analyses. Analysis of her extensive publication record (over 100 articles in the past five years) reveals a strong focus on causal inference methods, particularly Mendelian randomization, to untangle complex diet-disease relationships. Her research often bridges nutritional science with genetic epidemiology, examining how genetic predispositions interact with lifestyle factors to influence disease risk. Recent work has particularly emphasized connections between cardiovascular health, metabolic conditions, and gastrointestinal diseases. Dr. Larsson maintains an active research group with several doctoral students and affiliated researchers, including Stephanie Pitt and Shuai Yuan. Her collaborative approach is evident in the numerous multinational studies she participates in, often involving data from multiple countries across Europe, Asia, Australia, and North America. Her laboratory work focuses on the Cardiovascular and Nutritional Epidemiology Unit, which conducts population-based research examining how dietary patterns, lifestyle factors, and genetic predispositions influence chronic disease development and progression. The unit employs advanced epidemiological methods, including large-scale cohort studies, meta-analyses, and genetic epidemiology approaches to investigate causal relationships in public health.

• Cardiovascular Epidemiology
• Nutritional Epidemiology
• Cancer Epidemiology
• +4 more

Henrik Falconer serves as an Adjunct Senior Lecturer and Docent at Karolinska Institutet, where he leads the Gynecologic Cancer research group within the Department of Women's and Children's Health, Division for Neonatology, Obstetrics, Gynaecology and Reproductive Health. His career spans clinical practice, research leadership, and academic teaching in gynecologic oncology. Docent, Karolinska Institutet, 2015 Doctor of Philosophy, Department of Women's and Children's Health, Karolinska Institutet, 2008 University Medical Degree, Karolinska Institutet, 1998 Dr. Falconer's research focuses on clinical trials, cancer epidemiology, and translational research in gynecological malignancies. His work primarily investigates cervical cancer, ovarian cancer, and endometrial cancer, with emphasis on surgical techniques, cancer outcomes, and prevention strategies. He has pioneered research on minimally invasive surgical approaches, sentinel lymph node mapping, and fertility-sparing procedures in gynecologic oncology. Analysis of Dr. Falconer's recent publications reveals a strong focus on multinational collaborative studies examining surgical outcomes in cervical cancer (particularly the SCCAN studies), innovative approaches to ovarian cancer management, and the psychological impact of gynecologic cancers. His work spans clinical trials, epidemiological analyses, and translational research with practical clinical applications. Dr. Falconer leads several significant research projects including the RACC-trial (Robot-assisted Approach to Cervical Cancer), a major international randomized controlled trial investigating the oncologic safety of robotic surgery for cervical cancer. He also leads research on salpingectomy for ovarian cancer prevention and collaborates on the IPLA-OVCA trial investigating intraperitoneal anesthetics in ovarian cancer surgery. His research group maintains extensive national and international collaborations, working with all university hospitals in Sweden and multiple international partners. The group includes several PhD students and affiliated researchers focusing on various aspects of gynecologic oncology.

• Gynecologic Oncology
• Cervical Cancer
• Ovarian Cancer
• +4 more

Rikard Landberg is a Professor at Chalmers University of Technology's Department of Food Science, specializing in Food and Health research. His work focuses on the effects of food components on health outcomes, particularly plant-based diets, cardiometabolic risk factors, and biomarkers development. His group uses nutritional metabolomics (MS and NMR techniques) to identify biomarkers for dietary exposure and disease risk. Collaborations span international teams in statistics, epidemiology, and medicine. Key research themes include appetite regulation, hormone metabolism, and gut microbiota interactions. Landberg leads projects analyzing dietary patterns, metabolic responses, and translational studies linking food science to clinical outcomes. Research Interests: Plant-based diets and cardiometabolic health Metabolomics-based biomarker discovery Wholegrain and fiber impacts on obesity/diabetes Food component bioavailability Personalized nutrition strategies Recent Work Trends: 2025 publications emphasize mechanistic studies of dietary fibers (SCFAs, alkylresorcinols), randomized controlled trials on probiotics and Mediterranean diets, and population studies linking meat/plant metabolites to cardiovascular risks. His work bridges basic science with public health applications, often using multi-omics approaches. Grants & Collaborations: Active in EU-funded projects like LongITools and CRCbiome, involving multi-institutional teams across Europe. His lab collaborates with clinical groups on ADHD dietary interventions and cancer biomarker studies.

• Nutrition
• Cardiometabolic Health
• Nutritional Metabolomics
• +3 more